Most Read Articles
20 Jun 2020
The Lundbeck Neuroscience Symposium was held at Sofitel KL Damansara over 2 days, with extensivediscussions on the management of various mental illnesses. The second day of the symposiumaddressed the topic of schizophrenia management, focusing on treatment goals, the rationale forpartial dopamine D(2) receptor agonism and the use of long-acting injectable (LAI) antipsychotics topromote adherence.
Pearl Toh, 4 days ago
Having migraine during midlife appears to be associated with a higher risk of developing dementia in later life, according to a large population-based longitudinal Danish study presented at the AHS* 2020 Virtual Meeting, indicating that migraine may be a risk factor for dementia.
4 days ago
Patients with psoriatic arthritis (PsA) often suffer from liver abnormalities, which are associated with higher body mass index (BMI), daily consumption of alcohol, more severe disease, and some therapies, according to a recent study.
Christina Lau, 2 days ago

Pembrolizumab in combination with chemotherapy significantly improves progression-free survival (PFS) vs chemotherapy alone in patients with previously untreated, locally recurrent inoperable or metastatic triple-negative breast cancer (TNBC), results of the KEYNOTE-355 study have shown.

Folic acid treatment protective against CKD progression in certain patients

16 Nov 2019

Fortification or supplementation with folic acid may confer benefits for reducing the likelihood of chronic kidney disease (CKD) progression among patients with mild-to-moderate disease and elevated vitamin B12 levels, a recent study has found.

Researchers performed a posthoc analysis using data from the kidney disease substudy of the China Stroke Primary Prevention Trial (CSPPT), including 1,374 hypertensive adults with mild-to-moderate CKD. All participants had low folate intake and had undergone vitamin B12 measurements at baseline.

The participants were assigned to a double-blinded daily treatment of enalapril 10 mg alone or in combination with folic acid 0.8 mg. The primary endpoint was progression of CKD, defined as a reduction in estimated glomerular filtration rate (eGFR) ≥30 percent and to a level of <60 mL/min/1.73 m2 if baseline eGFR was ≥60 mL/min/1.73 m2; or a decrease in eGFR ≥50 percent if baseline value was <60 mL/min/1.73 m2; or kidney failure.

Mean eGFR at baseline in the cohort was 86.1 mL/min/1.73 m2, and the median treatment duration was 4.4 years. Compared with enalapril monotherapy, treatment with the enalapril–folic acid combo yielded an 83-percent reduction in the odds of CKD progression among participants with higher baseline B12 levels (≥248 pmol/L; odds ratio [OR], 0.17, 95 percent confidence interval [CI], 0.07–0.40).

The beneficial effect on the risk of progression was not observed among participants with lower baseline B12 levels (<248 pmol/L; metabolic B12 deficiency; OR, 1.21, 95 percent CI, 0.51–2.85). Baseline vitamin B12 levels had a significant interaction with folic acid treatment (p=0.001).

There were several limitations to the study, including those inherent in a posthoc analysis and the low event rate.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
20 Jun 2020
The Lundbeck Neuroscience Symposium was held at Sofitel KL Damansara over 2 days, with extensivediscussions on the management of various mental illnesses. The second day of the symposiumaddressed the topic of schizophrenia management, focusing on treatment goals, the rationale forpartial dopamine D(2) receptor agonism and the use of long-acting injectable (LAI) antipsychotics topromote adherence.
Pearl Toh, 4 days ago
Having migraine during midlife appears to be associated with a higher risk of developing dementia in later life, according to a large population-based longitudinal Danish study presented at the AHS* 2020 Virtual Meeting, indicating that migraine may be a risk factor for dementia.
4 days ago
Patients with psoriatic arthritis (PsA) often suffer from liver abnormalities, which are associated with higher body mass index (BMI), daily consumption of alcohol, more severe disease, and some therapies, according to a recent study.
Christina Lau, 2 days ago

Pembrolizumab in combination with chemotherapy significantly improves progression-free survival (PFS) vs chemotherapy alone in patients with previously untreated, locally recurrent inoperable or metastatic triple-negative breast cancer (TNBC), results of the KEYNOTE-355 study have shown.